FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

385103000: Conventional release cutaneous foam (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479365012 Cutaneous foam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3541111016 Conventional release cutaneous foam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3541112011 Conventional release cutaneous foam (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous foam est un(e) (attribut) Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Cutaneous foam est un(e) (attribut) Foam false Inferred relationship Some
Cutaneous foam est un(e) (attribut) forme cutanée true Inferred relationship Some
Cutaneous foam Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Cutaneous foam Has dose form intended site (attribute) Cutaneous (intended site) true Inferred relationship Some
Cutaneous foam Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Cutaneous foam Has basic dose form (attribute) Foam true Inferred relationship Some
Cutaneous foam Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g cutaneous foam a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Product containing precisely minoxidil 50 milligram/1 gram conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Calcipotriol 50 microgram/mL cutaneous foam a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Clindamycin 1% topical foam a une forme pharmaceutique (attribut) False Cutaneous foam Inferred relationship Some
Ibuprofen 50 mg/g cutaneous foam a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Clobetasol propionate 500 microgram/g cutaneous foam a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Desonide 500 microgram/mL cutaneous foam a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous foam (clinical drug) a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some
Betamethasone valerate 1.2 mg/mL cutaneous foam a une forme pharmaceutique (attribut) True Cutaneous foam Inferred relationship Some

This concept is not in any reference sets

Back to Start